Abstract
Background: Shared decision-making is gaining favor in clinical practice, although the extent to which patients want to be involved in choosing their treatment varies substantially. Because data are lacking on the preferences of patients with chronic diseases such as inflammatory bowel disease (IBD), we wanted to assess IBD patients’ preferences about being involved in such decisions. Methods: Adult IBD patients were asked to anonymously complete an online survey on their preferences. Non-parametric tests (χ2) were used to determine the relationship between responses and respondents. Results: The questionnaire was completed by 1,067 patients, 617 with Crohn’s disease and 450 with ulcerative colitis. Patients’ mean age was 43 (SD 13.7) years; the majority were female (66%). In total, 866 patients (81%) reported it as ‘very important’ to be actively involved in the decision-making process, and another 177 (17%) rated it as ‘quite important’. When asked how their treatment could be improved, 537 patients (50%) wanted close, equitable collaboration with their physician. This preference was significantly associated with a disease duration of ≤8 years (p = 0.03). Gender and type of IBD were not significantly associated with patients’ preferences. Conclusions: This study demonstrates IBD patients’ desire to be actively involved in the decision-making process. Further research is needed on physicians’ perspectives on shared decision-making, and on finding predictive factors for developing a model for shared decision-making in IBD.
Journal Section:
Original Paper
References
1.
Charles C, Gafni A, Whelan T: Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681–692.
[PubMed]
2.
Murray E, Pollack L, White M, Lo B: Clinical decision-making: Patients’ preferences and experiences. Patient Educ Couns 2007;65:189–196.
[PubMed]
3.
Légaré F, Ratté S, Gravel K, Graham ID: Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Patient Educ Couns 2008;73:526–535.
[PubMed]
4.
Siegel CA: Embracing the internet for progress in shared decision-making. Inflamm Bowel Dis 2007;13:1579–1580.
[PubMed]
5.
Kaplan SH, Greenfield S, Gandek B, Rogers WH, Ware JE Jr: Characteristics of physicians with participatory decision-making styles. Ann Intern Med 1996;124:497–504.
[PubMed]
6.
Levinson W, Kao A, Kuby A, Thisted RA: Not all patients want to participate in decision making. A national study of public preferences. J Gen Intern Med 2005;20:531–535.
[PubMed]
7.
Wallberg B, Michelson H, Nystedt M, Bolund C, Degner LF, Wilking N: Information needs and preferences for participation in treatment decisions among Swedish breast cancer patients. Acta Oncol 2000;39:467–476.
[PubMed]
8.
Stewart DE, Wong F, Cheung AM, Dancey J, Meana M, Cameron JI, McAndrews MP, Bunston T, Murphy J, Rosen B: Information needs and decisional preferences among women with ovarian cancer. Gynecol Oncol 2000;77:357–361.
[PubMed]
9.
Beaver K, Jones D, Susnerwala S, Craven O, Tomlinson M, Witham G, Luker KA: Exploring the decision-making preferences of people with colorectal cancer. Health Expect 2005;8:103–113.
[PubMed]
10.
Wong F, Stewart DE, Dancey J, Meana M, McAndrews MP, Bunston T, Cheung AM: Men with prostate cancer: influence of psychological factors on informational needs and decision making. J Psychosom Res 2000;49:13–19.
[PubMed]
11.
Degner LF, Sloan JA: Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol 1992;45:941–950.
[PubMed]
12.
Guadagnoli E, Ward P: Patient participation in decision-making. Soc Sci Med 1998;47:329–339.
[PubMed]
13.
Fraenkel L, McGraw S: Participation in medical decision making: the patients’ perspective. Med Decis Making 2007;27:533–538.
[PubMed]
14.
McKinstry B: Do patients wish to be involved in decision making in the consultation? A cross sectional survey with video vignettes. BMJ 2000;321:867–871.
[PubMed]
15.
Vogel BA, Bengel J, Helmes AW: Information and decision making: patients’ needs and experiences in the course of breast cancer treatment. Patient Educ Couns 2008;71:79–85.
[PubMed]
16.
Joosten EA, Fuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA: Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008;77:219–226.
[PubMed]
17.
Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–1517.
[PubMed]
18.
Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, Nielsen GL, Sorensen HT: Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002. Eur J Gastroenterol Hepatol 2006;18:601–606.
[PubMed]
19.
Lakatos PL: Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006;12:6102–6108.
[PubMed]
20.
Larsson K, Loof L, Ronnblom A, Nordin K: Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res 2008;64:139–148.
[PubMed]
21.
Vidal A, Gomez-Gil E, Sans M, Portella MJ, Salamero M, Pique JM, Panes J: Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis 2008;14:977–983.
[PubMed]
22.
Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP: Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 2005;54:237–241.
[PubMed]
23.
Meyer C, Muhlfeld A, Drexhage C, Floege J, Goepel E, Schauerte P, Kelm M, Rassaf T: Clinical research for patient empowerment – a qualitative approach on the improvement of heart health promotion in chronic illness. Med Sci Monit 2008;14:CR358–CR365.
24.
Aujoulat I, d’Hoore W, Deccache A: Patient empowerment in theory and practice: polysemy or cacophony? Patient Educ Couns 2007;66:13–20.
[PubMed]
25.
Kane SV, Cohen RD, Aikens JE, Hanauer SB: Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001;96:2929–2933.
[PubMed]
26.
Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP: Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 2002;8:244–250.
[PubMed]
27.
Ryan J, Sysko J: The contingency of patient preferences for involvement in health decision making. Health Care Manage Rev 2007;32:30–36.
[PubMed]
28.
Kane S, Huo D, Aikens J, Hanauer S: Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003;114:39–43.
[PubMed]
29.
Pieterse AH, Baas-Thijssen MC, Marijnen CA, Stiggelbout AM: Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer 2008;99:875–882.
[PubMed]
30.
Murray E, Pollack L, White M, Lo B: Clinical decision-making: physicians’ preferences and experiences. BMC Fam Pract 2007;8:10.
[PubMed]
31.
McGuire AL, McCullough LB, Weller SC, Whitney SN: Missed expectations? Physicians’ views of patients’ participation in medical decision-making. Med Care 2005;43:466–470.
[PubMed]
32.
Baars JE, Siegel CA, Kuipers EJ, van der Woude CJ: Patient’s perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease. Digestion 2009;79:30–35.
[PubMed]
© 2010 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2010
You do not currently have access to this content.
